Paradigm Biocapital Advisors LP Quant / Systematic

Location: New York, NY

CIK: 0001855655 · Show all filings

Period: Q4 2025 (← Previous) (Next →)

Filing Date: Feb 17, 2026

Total Value: $3.918B (100.0% shares, 0.0% debt)

Holdings (30)

NUVL NUVALENT INC 13.5%
Value $530M Shares 5,269,433 Est. Cost $60.72 Unrealized +62.4%
RVMD REVOLUTION MEDICINES INC 13.5%
Value $529M Shares 6,644,403 Est. Cost $38.36 Unrealized +70.9%
ACLX ARCELLX INC 9.5%
Value $373M Shares 5,724,016 Est. Cost $48.76 Unrealized +63.6%
GMAB GENMAB A/S 5.5%
Value $217M Shares 7,039,834 Est. Cost $30.73 Unrealized
TARS TARSUS PHARMACEUTICALS INC 5.4%
Value $210M Shares 2,562,154 Est. Cost $28.61 Unrealized +161.0%
ABVX ABIVAX SA 4.9%
Value $191M Shares 1,417,473 Est. Cost $84.90 Unrealized
OLMA OLEMA PHARMACEUTICALS INC 4.8%
Value $189M Shares 7,544,172 Est. Cost $9.20 Unrealized +93.4%
PCVX VAXCYTE INC 4.8%
Value $188M Shares 4,068,020 Est. Cost $55.45 Unrealized -19.3%
XBI SPDR SERIES TRUST 4.7%
Value $183M Shares 1,500,000 Est. Cost Unrealized
CIDARA THERAPEUTICS INC 4.3%
Value $168M Shares 759,565 Est. Cost $95.76 Unrealized
EWTX EDGEWISE THERAPEUTICS INC 4.1%
Value $162M Shares 6,541,210 Est. Cost $20.10 Unrealized -0.1%
SRRK SCHOLAR ROCK HLDG CORP 3.4%
Value $135M Shares 3,062,157 Est. Cost $33.97 Unrealized +10.4%
URGN UROGEN PHARMA LTD 2.7%
Value $105M Shares 4,473,648 Est. Cost $18.17 Unrealized +19.4%
CRNX CRINETICS PHARMACEUTICALS IN 2.6%
Value $103M Shares 2,210,774 Est. Cost $26.84 Unrealized +65.9%
APGE APOGEE THERAPEUTICS INC 2.2%
Value $84.78M Shares 1,123,243 Est. Cost $44.51 Unrealized +41.5%
EYPT EYEPOINT INC 1.7%
Value $67.44M Shares 3,691,475 Est. Cost $12.73 Unrealized +11.4%
ERAS ERASCA INC 1.3%
Value $52.67M Shares 14,159,095 Est. Cost $2.22 Unrealized +26.9%
BBIO BRIDGEBIO PHARMA INC 1.3%
Value $52.34M Shares 684,277 Est. Cost $36.37 Unrealized +80.5%
ORKA ORUKA THERAPEUTICS INC 1.3%
Value $51.84M Shares 1,710,316 Est. Cost $27.86 Unrealized 0.0%
SYRE SPYRE THERAPEUTICS INC 1.2%
Value $48.07M Shares 1,467,266 Est. Cost $26.04 Unrealized +0.3%
LXEO LEXEO THERAPEUTICS INC 1.2%
Value $47.3M Shares 4,763,198 Est. Cost $9.13 Unrealized 0.0%
VRDN VIRIDIAN THERAPEUTICS INC 1.1%
Value $44.91M Shares 1,443,102 Est. Cost $17.86 Unrealized +53.5%
OCUL OCULAR THERAPEUTIX INC 0.9%
Value $35.63M Shares 2,935,284 Est. Cost $7.86 Unrealized +54.4%
TERN TERNS PHARMACEUTICALS INC 0.8%
Value $32.74M Shares 810,286 Est. Cost $23.11 Unrealized 0.0%
BBOT BRIDGEBIO ONCOLOGY THERAPEUT 0.7%
Value $28.32M Shares 2,261,749 Est. Cost $11.74 Unrealized
VOR VOR BIOPHARMA INC 0.6%
Value $22.89M Shares 1,750,000 Est. Cost $18.62 Unrealized 0.0%
ASMB ASSEMBLY BIOSCIENCES INC 0.6%
Value $22.63M Shares 665,251 Est. Cost $32.21 Unrealized 0.0%
ORIC ORIC PHARMACEUTICALS INC 0.5%
Value $19.64M Shares 2,401,217 Est. Cost $11.51 Unrealized 0.0%
IVA INVENTIVA SA 0.5%
Value $18.6M Shares 4,000,000 Est. Cost $4.65 Unrealized
KLRS KALARIS THERAPEUTICS INC 0.2%
Value $5.908M Shares 700,000 Est. Cost $6.39 Unrealized 0.0%